ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,368,986 | -17.3% | 4,417,259 | 0.0% | 0.95% | -13.8% |
Q2 2023 | $58,484,509 | -2.7% | 4,417,259 | 0.0% | 1.10% | -18.9% |
Q1 2023 | $60,118,895 | -30.3% | 4,417,259 | 0.0% | 1.36% | -22.2% |
Q4 2022 | $86,269,068 | +2.5% | 4,417,259 | 0.0% | 1.75% | -2.5% |
Q3 2022 | $84,149,000 | -7.5% | 4,417,259 | 0.0% | 1.80% | -26.0% |
Q2 2022 | $90,996,000 | -36.0% | 4,417,259 | 0.0% | 2.43% | -21.8% |
Q1 2022 | $142,147,000 | -30.9% | 4,417,259 | 0.0% | 3.10% | -14.5% |
Q4 2021 | $205,668,000 | +72.4% | 4,417,259 | 0.0% | 3.63% | +119.4% |
Q3 2021 | $119,266,000 | +5.3% | 4,417,259 | 0.0% | 1.65% | -9.1% |
Q2 2021 | $113,303,000 | -25.0% | 4,417,259 | +0.0% | 1.82% | -20.1% |
Q1 2021 | $150,982,000 | +1.1% | 4,417,258 | 0.0% | 2.28% | +9.1% |
Q4 2020 | $149,392,000 | +37.1% | 4,417,258 | 0.0% | 2.09% | +4.8% |
Q3 2020 | $108,974,000 | – | 4,417,258 | – | 1.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |